Population-based lynch syndrome screening by microsatellite instability in patients ≤50: Prevalence, testing determinants, and result availability prior to colon surgery

American Journal of Gastroenterology

Volumn 110, Issue 7, 2015, Pages 948-955

  Karlitz, Jordan J ^a   Hsieh, Mei Chin ^b   Liu, Yong ^a   Blanton, Christine ^a   Schmidt, Beth ^b   Jessup, J Milburn ^c   Wu, Xiao Cheng ^b   Chen, Vivien W ^b  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MISMATCH REPAIR PROTEIN PMS2; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6;

ADULT; ARTICLE; COLON BIOPSY; COLON SURGERY; COLONOSCOPY; COMPARATIVE EFFECTIVENESS; FAMILY HISTORY; FEMALE; FIRST DEGREE RELATIVE; GENETIC SCREENING; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; PRIORITY JOURNAL; PUBLIC HOSPITAL; AGE; CLINICAL TRIAL; COLON RESECTION; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; EARLY DIAGNOSIS; GENETICS; MASS SCREENING; MIDDLE AGED; MULTICENTER STUDY; MULTIPLE CANCER; PREOPERATIVE PERIOD; PREVALENCE; PROCEDURES; RURAL POPULATION; SECOND CANCER; STANDARDS; STATISTICS AND NUMERICAL DATA; TIME; UNITED STATES; URBAN POPULATION;

ADULT; AGE FACTORS; COLECTOMY; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; CONFOUNDING FACTORS (EPIDEMIOLOGY); EARLY DETECTION OF CANCER; FEMALE; GENETIC TESTING; HUMANS; IMMUNOHISTOCHEMISTRY; LOUISIANA; MALE; MASS SCREENING; MICROSATELLITE INSTABILITY; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; NEOPLASMS, SECOND PRIMARY; PREOPERATIVE PERIOD; PREVALENCE; RURAL POPULATION; TIME FACTORS; UNITED STATES; URBAN POPULATION;

EID: 84936846687     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2014.417     Document Type: Article

References (28)

1. Van Lier MG, De Wilt JH, Wagemakers JJ, et al. Underutilization of microsatellite instability analysis in colorectal cancer patients at high risk for Lynch Syndrome. Scand J Gastroenterol 2009; 44: 600-4.
2. Jasperson KW, Tuohy TM, Neklason DW, et al. Hereditary and familial colon cancer. Gastroenterology 2010; 138: 2044-58.
3. Southey MC, Jenkins MA, Mead L, et al. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer. J Clin Oncol 2005; 23: 6524-32.
4. Win AK, Lindor NM, Young JP, et al. Risks of primary extracolonic cancers following colorectal cancer in Lynch syndrome. J Natl Cancer Inst 2012; 104: 1363-72.
5. Skeldon SC, Semotiuk K, Aronson M, et al. Patients with Lynch syndrome mismatch repair gene mutations are at higher risk for not only upper tract urothelial cancer but also bladder cancer. Eur Urol 2012; 63: 379-85.
6. Jarvinen HJ, Aarnio M, Mustonen H, et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 2000; 118: 829-34.
7. Parry S, Win AK, Parry B, et al. Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery. Gut 2011; 60: 950-7.
8. Win AK, Parry S, Parry B, et al. Risk of metachronous colon cancer following surgery for rectal cancer in mismatch repair gene mutation carriers. Ann Surg Oncol 2013; 20: 1829-36.
9. De Vos tot Nederveen Cappel WH, Buskens E, van Duijvendijk P, et al. Decision Analysis in the Surgical Treatment of Colorectal Cancer Due to a Mismatch Repair Gene Defect. Gut 2003; 52: 1752-5.
10. Giardello FM, Allen JI, Axilbund JE, et al. Guidelines on genetic evaluation and management of Lynch syndrome: A consensus statement by the US Multi-society task force of colorectal cancer. Am J Gastroenterol 2014; 109: 1159-79.
11. Unar A, Boland CR, Terdiman JP, et al. Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004; 96: 261-8.
12. National Comprehensive Cancer Network. Colorectal Cancer Screening (Version 1.2014) http://www.nccn.org/professionals/physician-gls/pdf/ colorectal-screening.pdf; Accessed on 22 April 2014
13. Palomaki GE, McClain MR, Melillo S, et al. EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome. Genet Med 2009; 11: 169-174.
14. Ligtenberg MJ, Kuiper RP, Geurts van Kessel A, et al. EPCAM deletion carriers constitute a unique subgroup of Lynch syndrome patients. Fam Cancer 2013; 12: 169-74.
15. Deng G, Bell I, Crawly S, et al. BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer. Clin Cancer Res 2004; 10: 191-5.
16. Lochhead P, Kuchiba A, Imamura Y, et al. Microsatellite instability and BRAF mutation testing in colorectal cancer prognostication. J Natl Cancer Inst 2013; 105: 1151-6.
17. Is high-grade dysplasia of the GI tract reportable?. http://seer.cancer.gov/ registrars/data-collection.htm l; Accessed on 12 August 2014.
18. American College of Surgeons CoC Accreditation Categories. https://www. facs.org/quality-programs/cancer/accredited/about/categories; Accessed on 2 August 2014.
19. Beamer L, Grant M, Espenschied C, et al. Refl ex immunohistochemistry and microsatellite instability testing of colorectal tumors for lynch syndrome among US cancer programs and follow-up of abnormal results. J Clin Oncol 2012; 30: 1058-63.
20. Cross DS, Rahm AK, Kauffman TL, et al. Underutilization of Lynch syndrome screening in a multisite study of patients with colorectal cancer. Genet Med 2013; 15: 933-40.
21. Hampel H, Stephens JA, Pukkala E, et al. Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset. Gastroenterology 2005; 129: 415-21.
22. Niessen RC, Berends MJW, Wu Y, et al. Identifi cation of mismatch repair gene mutations in young patients with colorectal cancer and in patients with multiple tumors associated with hereditary non-polyposis colorectal cancer. Gut 2006; 55: 1781-8.
23. Madlensky L. Is it time to embrace telephone genetic counseling in the oncology setting?. J Clin Oncol 2014; 32: 611-2.
24. d'Agincourt-Canning L, McGillivray B, Panabaker K, et al. Evaluation of genetic counseling for hereditary cancer by videoconference in British Columbia. BCMJ 2008; 50: 554-9.
25. Heald B, Plesec T, Liu X, et al. Implementation of universal microsatellite instability and immunohistochemistry screening for diagnosing lynch syndrome in a large academic medical center. J Clin Oncol 2013; 31: 1336-40.
26. LSU Pennington Biomedical Research Center. http://www.lsusystem.edu/ index.php/institutions/lsu-pennington-biomedical-research-center/; Accessed on 11 May 2014.
27. Aaltonen LA, Salovaara R, Kristo P, et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 1998; 338: 1481-7.
28. Wright DM, Arnold JL, Parry B, et al. Immunohistochemistry to detect hereditary polyposis colorectal cancer in young patients: the 7-year Auckland experience. Dis Colon Rectum 2011; 54: 552-8.